Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$13.78 USD
+0.81 (6.25%)
Updated May 15, 2024 04:00 PM ET
After-Market: $13.73 -0.05 (-0.36%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.89 |
EPS Last Quarter | -0.97 |
Last EPS Surprise | -4.30% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.59 |
Next Year | -1.72 |
EPS (TTM) | -3.40 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 23.97M | 25.72M | 99.38M | 172.16M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 24.50M | 26.43M | 99.75M | 180.82M |
Low Estimate | 23.44M | 25.00M | 99.00M | 163.50M |
Year ago Sales | 21.14M | 20.85M | 82.71M | 99.38M |
Year over Year Growth Est. | 13.39% | 23.33% | 20.14% | 73.24% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.89 | -0.90 | -3.59 | -1.72 |
# of Estimates | 2 | 2 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.85 | -0.87 | -3.30 | -0.10 |
Low Estimate | -0.93 | -0.93 | -3.90 | -3.13 |
Year ago EPS | -1.03 | -0.68 | -3.55 | -3.59 |
Year over Year Growth Est. | 13.59% | -32.35% | -1.13% | 52.23% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.89 | -0.90 | -3.59 | -1.72 |
7 Days Ago | -0.89 | -0.90 | -3.59 | -1.75 |
30 Days Ago | -0.89 | -0.90 | -3.59 | -1.75 |
60 Days Ago | -0.70 | -0.68 | -3.19 | -1.62 |
90 Days Ago | -0.69 | -0.63 | -2.66 | -1.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.89 | -0.90 | -3.59 | -1.61 |
Zacks Consensus Estimate | -0.89 | -0.90 | -3.59 | -1.72 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 6.26% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.97 | -0.72 | -0.68 | -1.03 | NA |
Estimate | -0.93 | -0.67 | -0.89 | -1.13 | NA |
Difference | -0.04 | -0.05 | 0.21 | 0.10 | 0.06 |
Surprise | -4.30% | -7.46% | 23.60% | 8.85% | 5.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more